M.A. Selepe et al. / Tetrahedron 67 (2011) 8654e8658
8657
lock. The chemical shifts from 1H NMR and 13C NMR spectra are
reported in parts per million relative to the residual protonated or
deuterated solvents peaks (CDCl3: dH 7.26, dc 77.0; CD3OD: dH 3.31,
dc 49.0 and acetone-d6: dH 2.05, dc 205.1). The mass spectra were
recorded on a time-of-flight mass spectrometer using electrospray
ionisation in the positive or negative mode. IR spectra were
recorded with FT-IR spectrophotometer.
evaporation of the solvent afforded the boronic acid 6 as an orange
soild (2.76 g, 74%): IR (neat) nmax 3385, 2957, 1726, 1603, 1142,
993 cmꢁ1; 1H NMR (CDCl3, 400 MHz)
d
7.79 (1H, d, J¼8.4 Hz, H-6),
6.80 (1H, d, J¼2.0 Hz, H-3), 6.76 (1H, dd, J¼2.0 and 8.4 Hz, H-5),
6.68 (2H, br s, B(OH)2), 5.27 (2H, s, OCH2O), 5.19 (2H, s, OCH2O),
3.50 (3H, s, OCH3), 3.47 (3H, s, OCH3); 13C NMR (CDCl3, 100 MHz)
d
163.5 (C, C-2), 160.9 (C, C-4), 137.8 (CH, C-6), 109.3 (CH, C-5),
102.1 (CH, C-3), 94.6 (OCH2O), 94.0 (OCH2O), 56.4 (OCH3), 56.0
(OCH3), (C-1 signal not observed); 11B NMR (CDCl3, 128 MHz) dB
28.55.
4.2. Synthesis
4.2.1. 1,3-Dimethoxymethoxybenzene (8)30. Catalytic ZnBr2 was
dissolved in dimethoxymethane (16.0 mL, 0.182 mol) under nitro-
gen atmosphere, and then acetyl chloride (12.9 mL, 0.182 mol) was
added dropwise to the stirred solution. The solution was stirred for
an additional 2 h at rt then transferred via a cannula to the ice-cold
solution of resorcinol (7) (5.00 g, 45.4 mmol) and (i-Pr)2EtN
(23.3 mL, 0.136 mol) in CH2Cl2 (100 mL) under a nitrogen atmo-
sphere. The mixture was stirred for 3 h, diluted with saturated
NH4Cl solution and stirred for an additional 15 min. The two phases
were partitioned and the aqueous phase was extracted with CH2Cl2.
The combined organic extracts were washed with brine and dried
over anhydrous MgSO4. The solvent was evaporated to give a yel-
low oil, which was purified by column chromatography using Hex/
EtOAc (9:1) to give 8 as a colorless oil (5.4 g, 60%): IR (neat) nmax
4.2.4. 20,40,5,7-Tetramethoxymethoxyisoflavone (10). To a solution of
3-iodochromone 5 (1.20 g, 3.06 mmol) in 1:1 DME/H2O (50 mL)
were added 10% Pd/C (0.160 g, 5 mol %), Na2CO3 (0.970 g,
9.18 mmol) and phenylboronic acid 6 (1.11 g, 4.59 mmol). The
resulting mixture was stirred at 40e45 ꢂC overnight. The catalyst
was filtered and washed with water and EtOAc. The aqueous phase
was extracted with EtOAc, and the combined organic layers were
washed with water, brine and dried over anhydrous MgSO4. The
solvent was evaporated and the crude product was purified by silica
gel column chromatography using Hex/EtOAc (7:3) to afford an
isoflavone 10 (1.1 g, 78%) as a yellow oil: IR (neat) nmax 2905, 2828,
1647, 1609, 1570, 1256, 1150, 999, 918 cmꢁ1 1H NMR (CDCl3,
;
400 MHz)
d
7.75 (1H, s, H-2), 7.22 (1H, d, J¼8.5 Hz, H-60), 6.88 (1H, d,
2955, 2902, 2827, 1768, 1591, 1487, 1219, 1138, 1004, 772 cmꢁ1
NMR (CDCl3, 400 MHz)
;
1H
J¼2.3 Hz, H-30), 6.76e6.72 (3H, m, H-6, H-8, H-50), 5.27 (2H, s,
OCH2O), 5.23 (2H, s, OCH2O), 5.17 (2H, s, OCH2O), 5.10 (2H, s,
OCH2O), 3.52 (3H, s, OCH3), 3.50 (3H, s, OCH3), 3.47 (3H, s, OCH3),
d
7.19 (1H, t, J¼8.3 Hz, H-5), 6.75 (1H, t,
J¼2.3 Hz, H-2), 6.71 (2H, dd, J¼2.3 and 8.3 Hz, H-4 and H-6), 5.16
(4H, s, 2ꢀ OCH2O), 3.48 (6H, s, 2ꢀ OCH3); 13C NMR (CDCl3,
3.41 (3H, s, OCH3); 13C NMR (CDCl3, 100 MHz)
d 174.9 (C, C-4), 160.9
100 MHz)
d
158.3 (2ꢀ C, C-1 and C-3), 129.9 (CH, C-5), 109.6 (2ꢀ CH,
(C, C-7), 159.4 (C, C-8a), 158.5 (C, C-5), 158.4 (C, C-40), 156.2 (C, C-20),
151.8 (CH, C-2), 132.4 (CH, C-60), 123.1 (C, C-3), 115.5 (C, C-10), 111.5
(C, C-4a), 108.9 (CH, C-50), 104.1 (CH, C-30), 102.4 (CH, C-6), 97.3 (CH,
C-8), 95.8 (CH2, OCH2O), 95.1 (CH2, OCH2O), 94.5 (CH2, OCH2O), 94.3
(CH2, OCH2O), 56.5 (CH3, OCH3), 56.4 (CH3, OCH3), 56.1 (CH3, OCH3),
56.0 (CH3, OCH3); HRMS-ESI m/z [MþNa]þ calcd for C23H26NaO10
485.1424, found 485.1415.
C-4 and C-6), 105.0 (CH, C-2), 94.5 (2ꢀ OCH2O), 55.9 (2ꢀ OCH3);
LRMS-ESI m/z [M]þ 198.1.
4.2.2. 1-Iodo-2,4-dimethoxymethoxybenzene (9). CH3CO2Ag (5.10 g,
30.3 mmol) was added to a solution of 8 (5.00 g, 25.2 mmol) in
CHCl3 (50 mL). The mixture was stirred for 5 min, and then a so-
lution of I2 (7.04 g, 27.7 mmol) in CHCl3 (150 mL) was added
dropwise to the stirred suspension. The resulting mixture was
stirred at rt for 5 h and filtered to remove the AgI. The filtrate was
washed with 10% Na2S2O3 solution, 5% NaHCO3 solution, H2O and
brine. The organic phase was dried over anhydrous MgSO4 and the
solvent evaporated to give a colourless oil. The oil was purified by
flash chromatography using Hex/EtOAc (9:1) to afford the iodin-
ated compound 9 as a colorless oil (7.76 g, 95%): IR (neat) nmax
2956, 2902, 2826, 1716, 1577, 1567, 1474, 1219, 1149, 982,
4.2.5. 20,40,5,7-Tetrahydroxyisoflavone (4)25,26. HCl (3 M, 15 mL)
was added to a solution of 10 (1.00 g, 2.16 mmol) in CH3OH
(30 mL) and stirred at 50 ꢂC for 12 h. CH3OH was evaporated and
the reaction mixture was extracted with EtOAc. The combined
organic phases were washed with H2O and brine. The organic
layer was dried over anhydrous MgSO4 and the solvent evaporated
under reduced pressure to give a yellow solid. Purification of the
solid by column chromatography using Hex/EtOAc (1:1) afforded 4
as a pale yellow solid (0.45 g, 73%): recrystallization of 4 from Hex/
EtOAc (1:4) gave pale yellow needles. Mp 268.4e270.1 ꢂC (lit.26
mp 272.0 ꢂC); IR (neat) nmax 3319, 1652, 1613, 1502, 1254,
772 cmꢁ1; 1H NMR (CDCl3, 400 MHz)
d
7.62 (1H, d, J¼8.5 Hz, H-6),
6.80 (1H, d, J¼2.5 Hz, H-3), 6.53 (1H, dd, J¼2.5 and 8.5 Hz, H-5),
5.21 (2H, s, OCH2O), 5.13 (2H, s, OCH2O), 3.50 (3H, s, OCH3), 3.46
(3H, s, OCH3); 13C NMR (CDCl3, 100 MHz)
d
158.7 (C, C-4), 156.7 (C,
1171 cmꢁ1 1H NMR (CD3OD, 400 MHz)
; d 8.00 (1H, s, H-2), 7.04
C-2), 139.2 (CH, C-6), 111.4 (CH, C-5), 104.4 (CH, C-3), 95.0 (CH2,
OCH2O), 94.5 (CH2, OCH2O), 77.4 (C, C-1), 56.4 (CH3, OCH3), 56.0
(CH3, OCH3); HRMS-ESI m/z [MþNa]þ calcd for C10H13INaO4
346.9756, found 346.9754.
(1H, d, J¼8.2 Hz, H-60), 6.40 (1H, d, J¼2.3 Hz, H-30), 6.37 (1H, dd,
J¼2.3 and 8.2 Hz, H-50), 6.36 (1H, d, J¼2.3 Hz, H-8), 6.23 (1H, d,
J¼2.3 Hz, H-6); 13C NMR (CD3OD, 100 MHz)
d 182.7 (C, C-4), 166.2
(C, C-7), 163.7 (C, C-5), 160.2 (C, C-40), 159.8 (C, C-8a), 157.8 (C, C-
20), 156.7 (CH, C-2), 133.2 (CH, C-60), 122.6 (C, C-3), 110.9 (C, C-10),
108.2 (CH, C-50), 106.2 (C, C-4a), 104.4 (CH, C-30), 100.3 (CH, C-6),
94.9 (CH, C-8), HRMS-ESI m/z [MꢁH]ꢁ calcd for C15H9O6 285.0399,
found 285.0399.
4.2.3. 2,4-Dimethoxymethoxyphenylboronic acid (6)27. Triisopropyl
borate (10.7 mL, 46.3 mmol) was added to the stirred solution of
aryl iodide 9 (5.00 g, 15.4 mmol) in THF/Et2O (1:2, 100 mL) under
N2. The solution was cooled to ꢁ100 ꢂC using liquid N2 and CH3OH
bath, and then n-BuLi (14.5 mL of a 1.6 M solution in hexanes,
23.2 mmol) was added slowly with stirring. After 1 h of stirring at
the temperature below ꢁ78 ꢂC, saturated NH4Cl solution was
added. The solution was stirred for an additional 1 h at rt and the
two phases partitioned. The aqueous phase was extracted with
Et2O. The combined organic phases were washed with H2O and
brine, and dried over anhydrous MgSO4. The solvent was evapo-
rated under reduced pressure to give an orange oil. Purification of
the oil by column chromatography (8:2 Hex/EtOAc) and
4.2.6. Lupinalbin A (3)23. DDQ (79.0 mg, 0.349 mmol) was added
under N2 to a solution of 4 (100 mg, 0.35 mmol) in THF (20 mL). The
reaction mixture was heated to 60 ꢂC with stirring for 15 min.
Additional DDQ (79.0 mg, 0.349 mmol) was added to the mixture
and stirring was continued at the same temperature for 30 min. The
solvent was evaporated and the crude mixture purified by column
chromatography using Hex/EtOAc as eluent to give coumar-
onochromone 3 (66 mg, 66%) as a white solid: 3 was recrystallized
from Hex/EtOAc (1:4) to afford white needle-like crystals, which